NCT07237464 2025-11-19To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Healthy ParticipantsKexing Biopharm Co., Ltd.Phase 1 Recruiting36 enrolled